IP Library Patent Application 18126344
Patent Application
App. No. 18/126,344

METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/126,344
Abstract

The invention provides methods for simultaneously amplifying multiple nucleic acid regions of interest in one reaction volume as well as methods for selecting a library of primers for use in such amplification methods. The invention also provides library of primers with desirable characteristics, such as minimal formation of amplified primer dimers or other non-target amplicons.

Claims (23)

1 . A method for amplifying and sequencing DNA, comprising:

ligating adaptors to DNA isolated from a biological sample, wherein the adaptors each comprises a universal priming sequence and a molecular barcode;

performing a first PCR to simultaneously amplify 10 to 20,000 target loci using a first universal primer and 10 to 20,000 target-specific primers in a single reaction volume;

performing a second, nested PCR to simultaneously amplify the 10 to 20,000 target loci using a second universal primer and 10 to 20,000 inner target-specific primers in a single reaction volume, wherein at least one of the primers comprises a sequencing tag; and

performing high-throughput sequencing to sequence the amplified DNA comprising the target loci.

2 . The method of claim 1 , wherein the biological sample is a tissue sample.

3 . The method of claim 1 , wherein the method comprises subjecting the isolated DNA to blunting ending, dA-tailing, and adaptor ligation.

4 . The method of claim 1 , wherein the second PCR is one-sided nested PCR.

5 . The method of claim 1 , wherein the method comprises multiplex sequencing of amplified DNA of multiple samples in a single sequencing lane.

6 . The method of claim 1 , wherein the first PCR comprises simultaneously amplifying between 100 and 5,000 target loci using the first universal primer and between 100 and 5,000 target specific primers in a single reaction volume.

7 . The method of claim 6 , wherein the second PCR comprises simultaneously amplifying between 100 and 5,000 target loci using the second universal primer and between 100 and target-specific primers in a single reaction volume.

8 . The method of claim 1 , wherein the first PCR comprises simultaneously amplifying between 100 and 1,000 target loci using the first universal primer and between 100 and 1,000 inner target-specific primers in a single reaction volume.

9 . The method of claim 8 , wherein the second PCR comprises simultaneously amplifying between 100 and 1,000 target loci using the second universal primer and between 100 and 1,000 inner target-specific primers in a single reaction volume.

10 . The method of claim 1 , wherein the isolated DNA are tagged with up to 1024 different molecular barcodes.

11 . The method of claim 1 , wherein the isolated DNA are tagged with 1024 −65536 different molecular barcodes.

12 . The method of claim 1 , wherein the concentration of each target-specific primer of the first and/or second PCR is less than 20 nM.

13 . The method of claim 1 , wherein the concentration of each target-specific primer of the first and/or second PCR is less than 10 nM.

14 . The method of claim 1 , wherein the length of the annealing step of the first and/or second PCR is at least 3 minutes.

15 . The method of claim 1 , wherein the length of the annealing step of the first and/or second PCR is at least 5 minutes.

16 . The method of claim 1 , wherein at least 90% of the amplified DNA map to the target loci.

17 . The method of claim 1 , wherein the target loci are SNP loci.

18 . The method of claim 1 , wherein the DNA comprises DNA from a tumor.

19 . The method of claim 7 , wherein amplified DNAs of multiple samples are pooled and sequenced in a single sequencing lane.